ALRS Stock Analysis: Alerus Financial | NASDAQ
Banks - Regional | NASDAQ, USA | Market Cap: 854m USD | 12M Return: 59.3% | US01446U1034 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 4.00M
EPS Trend: 90.4%
Qual. Beats: 0
Rev. Trend: 73.4%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Alerus Financial Corporation (ALRS) is a U.S. bank holding company headquartered in Grand Forks, North Dakota, founded in 1879 and formerly known as First National Bank North Dakota. It operates through three segments: Banking, Retirement and Benefit Services, and Wealth, serving both businesses and consumers. Its banking offerings include demand and time deposits, treasury management products, commercial and consumer loans, commercial real estate financing, mortgages, and digital banking services. The Retirement and Benefit Services segment provides recordkeeping and administration for retirement plans, HSAs, FSAs, and COBRA, while the Wealth segment delivers investment advisory, financial planning, trust, estate administration, and custody services.
As a bank holding company, Alerus is regulated by the Federal Reserve and operates a diversified financial services model that combines traditional spread-based banking with fee-generating businesses such as retirement plan administration and wealth management. This mix of net interest income and recurring fee revenue is typical of community and regional banks seeking to reduce earnings volatility tied to interest rate cycles.
- Net interest margin compression as Fed cuts rates pressure spreads
- Retirement and Benefit Services fees drive diversified revenue growth
- Commercial real estate loan portfolio faces credit risk in higher rate environment
| Net Income: 30.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 1.22 > 1.0 |
| NWC/Revenue: -68.49% < 20% (prev -1.01k%; Δ 942.8% < -1%) |
| CFO/TA 0.02 > 3% & CFO 114.0m > Net Income 30.0m |
| Net Debt (396.4m) to EBITDA (55.2m): 7.18 < 3 |
| Current Ratio: 0.27 > 1.5 & < 3 |
| Outstanding Shares: last quarter (25.2m) vs 12m ago -2.15% < -2% |
| Gross Margin: 73.05% > 18% (prev 68.44%; Δ 4.61% > 0.5%) |
| Asset Turnover: 6.30% > 50% (prev 7.36%; Δ -1.06% > 0%) |
| Interest Coverage Ratio: 0.40 > 6 (EBIT TTM 37.5m / Interest Expense TTM 93.7m) |
| A: -0.04 (Total Current Assets 86.8m - Total Current Liabilities 318.4m) / Total Assets 5.40b |
| B: 0.06 (Retained Earnings 316.8m / Total Assets 5.40b) |
| C: 0.01 (EBIT TTM 37.5m / Avg Total Assets 5.37b) |
| D: 0.12 (Book Value of Equity 576.9m / Total Liabilities 4.83b) |
| Altman-Z'' = 0.08 = B |
| DSRI: 1.13 (Receivables 21.0m/21.6m, Revenue 338.2m/392.2m) |
| GMI: 0.94 (GM 68.44% / 73.05%) |
| AQI: 1.11 (AQ_t 0.96 / AQ_t-1 0.86) |
| SGI: 0.86 (Revenue 338.2m / 392.2m) |
| TATA: -0.02 (NI 30.0m - CFO 114.0m) / TA 5.40b) |
| Beneish M = -3.01 (Cap -4..+1) = AA |
As of November 20, 2026, the stock is trading at USD 32.55 with a total of 109,123 shares traded. Over the past week, the price has changed by -5.02%, over one month by +4.46%, over three months by +0.29% and over the past year by +59.26%.
Current recommended Stop Loss: 31.50 (which is 3.2% or 1.2 ATR below the current price).
Alerus Financial has received a consensus analysts rating of 3.40. Therefore, it is recommended to hold ALRS.
- StrongBuy: 0
- Buy: 2
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 36.4 | 11.8% |
P/E Trailing = 28.9916
P/S = 3.4396
P/B = 1.477
Revenue TTM = 338.2m USD
EBIT TTM = 37.5m USD
EBITDA TTM = 55.2m USD
Long Term Debt = 59.3m USD (from longTermDebt, last quarter)
Short Term Debt = 318.4m USD (from shortTermDebt, last quarter)
Debt = 462.1m USD (from shortLongTermDebtTotal, last quarter) + Leases 42.2m
Net Debt = 396.4m USD (calculated: Debt 462.1m - CCE 65.8m)
Enterprise Value = 1.25b USD (853.7m + Debt 462.1m - CCE 65.8m)
Interest Coverage Ratio = 0.40 (Ebit TTM 37.5m / Interest Expense TTM 93.7m)
EV/FCF = 11.19x (Enterprise Value 1.25b / FCF TTM 111.7m)
FCF Yield = 8.94% (FCF TTM 111.7m / Enterprise Value 1.25b)
FCF Margin = 33.04% (FCF TTM 111.7m / Revenue TTM 338.2m)
Net Margin = 8.87% (Net Income TTM 30.0m / Revenue TTM 338.2m)
Gross Margin = 73.05% ((Revenue TTM 338.2m - Cost of Revenue TTM 91.2m) / Revenue TTM)
Gross Margin QoQ = 75.45% (prev 77.40%)
Tobins Q-Ratio = 0.23 (Enterprise Value 1.25b / Total Assets 5.40b)
Interest Expense / Debt = 20.27% (Interest Expense 93.7m / Debt 462.1m)
Taxrate = 23.48% (9.20m / 39.2m)
NOPAT = 28.7m (EBIT 37.5m * (1 - 23.48%))
Current Ratio = 0.27 (Total Current Assets 86.8m / Total Current Liabilities 318.4m)
Debt / Equity = 0.80 (Debt 462.1m / totalStockholderEquity, last quarter 576.9m)
Debt / EBITDA = 7.18 (Net Debt 396.4m / EBITDA 55.2m)
Debt / FCF = 3.55 (Net Debt 396.4m / FCF TTM 111.7m)
Total Stockholder Equity = 574.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.56% (Net Income 30.0m / Total Assets 5.40b)
RoE = 5.22% (Net Income TTM 30.0m / Total Stockholder Equity 574.9m)
RoCE = 5.91% (EBIT 37.5m / Capital Employed (Equity 574.9m + L.T.Debt 59.3m))
RoIC = 0.53% (NOPAT 28.7m / Invested Capital 5.39b)
WACC = 10.62% (E(853.7m)/V(1.32b) * Re(7.98%) + D(462.1m)/V(1.32b) * Rd(20.27%) * (1-Tc(0.23)))
Discount Rate = 7.98% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 67.60 | Cagr: 10.62%
[DCF] Terminal Value 70.98% ; FCFF base≈85.2m ; Y1≈97.6m ; Y5≈143.7m
[DCF] Fair Price = 46.28 (EV 1.54b - Net Debt 396.4m = Equity 1.15b / Shares 24.7m; r=10.62% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 90.41 | EPS CAGR: 46.20% | SUE: 0.27 | # QB: 0
Revenue Correlation: 73.35 | Revenue CAGR: 13.21% | SUE: 0.81 | # QB: 0
EPS current Quarter (2027-03-31): EPS=0.68 | Chg30d=+3.65% | Revisions=+62% | Analysts=5
EPS current Year (2026-12-31): EPS=3.11 | Chg30d=+2.98% | Revisions=+62% | GrowthEPS=+11.7% | GrowthRev=+7.8%
EPS next Year (2027-12-31): EPS=2.92 | Chg30d=+3.62% | Revisions=+62% | GrowthEPS=-5.9% | GrowthRev=+2.9%
[Analyst] Revisions Ratio: +83% (up=15, down=0)